IMTX
Immatics NV
NASDAQ: IMTX · HEALTHCARE · BIOTECHNOLOGY
$10.99
-1.87% today
Updated 2026-04-30
Market cap
$1.50B
P/E ratio
—
P/S ratio
31.12x
EPS (TTM)
$-1.89
Dividend yield
—
52W range
$4 – $12
Volume
0.5M
Immatics NV (IMTX) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | $61.32M | $134.28M | $254.65M | $174.65M | $407.82M | $509.96M | $696.15M |
| Cash & equivalents | — | — | — | — | — | — | — |
| Current assets | $55.29M | $124.00M | $238.99M | $152.21M | $377.15M | $449.37M | $629.55M |
| Total liabilities | $70.49M | $175.11M | $150.39M | $150.58M | $194.66M | $284.88M | $121.30M |
| Current liabilities | $26.84M | $69.30M | $60.61M | $95.15M | $106.45M | $156.55M | $67.99M |
| Long-term debt | — | — | — | — | — | — | — |
| Shareholder equity | — | — | — | — | — | — | — |
| Retained earnings | $-201.62M | $-233.19M | $-462.25M | $-537.81M | $-500.30M | $-597.29M | $-589.54M |
| Accounts receivable | $1.82M | $2.72M | $2.92M | $2.36M | $1.11M | $5.74M | $6.75M |
| Inventory | $1.00 | $1.24M | $3.30M | $1.00 | $1.00 | $1.00 | — |
| Goodwill | — | — | — | — | — | — | — |